May 15, 2026 · Form 4 insider transaction
HALBERT JON bought 68,000 shares of Caris Life Sciences, Inc. at $14.56 per share, a transaction worth $990.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 59 days after the transaction.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.49 to $14.60 inclusive. The reporting person undertakes to provide to Caris Life Sciences, Inc., any security holder of Caris Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.; Includes an aggregate of 11,598 shares received in pro rata distributions exempt pursuant to Rule 16a-9.; The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.